Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning.

Journal: International journal of radiation oncology, biology, physics
Published Date:

Abstract

PURPOSE: To explore the prostate-specific membrane antigen (PSMA)-avid distribution of prostate cancer (PC) on positron emission tomography (PET), both at the time of initial diagnosis and at the time of relapse after definitive local treatment.

Authors

  • Sandeep K Gupta
    Department of Nuclear Medicine & PET, John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia; University of Newcastle, Newcastle, New South Wales, Australia. Electronic address: Sandeep.Gupta@hnehealth.nsw.gov.au.
  • Tahne Watson
    Department of Nuclear Medicine & PET, John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia.
  • Jim Denham
    University of Newcastle, Newcastle, New South Wales, Australia; Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, New South Wales, Australia.
  • Thomas P Shakespeare
    Radiation Oncology, Mid North Coast Cancer Institute and University of New South Wales Rural Clinical School, Coffs Harbour, New South Wales, Australia.
  • Natalie Rutherford
    Department of Nuclear Medicine & PET, John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia; University of Newcastle, Newcastle, New South Wales, Australia.
  • Nicholas McLeod
    Department of Urology, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Kevin Picton
    Department of Nuclear Medicine & PET, John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia; University of Newcastle, Newcastle, New South Wales, Australia.
  • Paul Ainsworth
    Department of Urology, John Hunter Hospital, Newcastle, New South Wales, Australia; Hunter Urology, Hamilton, Newcastle, New South Wales, Australia.
  • Tony Bonaventura
    University of Newcastle, Newcastle, New South Wales, Australia; Department of Medical Oncology, Calvary Mater Hospital, Newcastle, New South Wales, Australia.
  • Jarad M Martin
    University of Newcastle, Newcastle, New South Wales, Australia; Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, New South Wales, Australia.